TN2013000045A1 - Anti-n3pglu amyloid beta peptide antibodies and uses thereof - Google Patents

Anti-n3pglu amyloid beta peptide antibodies and uses thereof

Info

Publication number
TN2013000045A1
TN2013000045A1 TNP2013000045A TN2013000045A TN2013000045A1 TN 2013000045 A1 TN2013000045 A1 TN 2013000045A1 TN P2013000045 A TNP2013000045 A TN P2013000045A TN 2013000045 A TN2013000045 A TN 2013000045A TN 2013000045 A1 TN2013000045 A1 TN 2013000045A1
Authority
TN
Tunisia
Prior art keywords
amyloid beta
beta peptide
peptide antibodies
n3pglu
n3pglu amyloid
Prior art date
Application number
TNP2013000045A
Other languages
French (fr)
Inventor
Jirong Lu
Ying Tang
Ronald Bradley Demattos
Original Assignee
Lilly Co Eli
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from PCT/US2011/046994 external-priority patent/WO2012021469A1/en
Application filed by Lilly Co Eli filed Critical Lilly Co Eli
Publication of TN2013000045A1 publication Critical patent/TN2013000045A1/en

Links

Abstract

The present invention provides anti-N3pGlu Aâ antibodies or antigen-binding fragment thereof. In addition, the present invention provides the use of the anti-N3pGlu Aâ antibodies or antigen-binding fragment thereof for the treatment of Alzheimers disease.
TNP2013000045A 2011-08-09 2013-02-01 Anti-n3pglu amyloid beta peptide antibodies and uses thereof TN2013000045A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/US2011/046994 WO2012021469A1 (en) 2010-08-12 2011-08-09 ANTI-N3pGlu AMYLOID BETA PEPTIDE ANTIBODIES AND USES THEREOF

Publications (1)

Publication Number Publication Date
TN2013000045A1 true TN2013000045A1 (en) 2014-06-25

Family

ID=54360753

Family Applications (1)

Application Number Title Priority Date Filing Date
TNP2013000045A TN2013000045A1 (en) 2011-08-09 2013-02-01 Anti-n3pglu amyloid beta peptide antibodies and uses thereof

Country Status (1)

Country Link
TN (1) TN2013000045A1 (en)

Similar Documents

Publication Publication Date Title
MX355268B (en) ANTI-N3pGlu AMYLOID BETA PEPTIDE ANTIBODIES AND USES THEREOF.
MX2018005720A (en) Pd-l1 antibody, antigen fragment binding thereof and pharmaceutical use thereof.
WO2014124334A3 (en) Transthyretin antibodies and uses thereof
NZ727020A (en) Antibodies and antigen-binding fragments that specifically bind to microtubule-associated protein tau
NZ730763A (en) Methods of treating a tauopathy
MA34091B1 (en) Antibody antibody cd40
EP3702372A3 (en) Anti-cd40 human antibodies
SG194701A1 (en) Anti-cd40 antibodies and methods of use
NZ707086A (en) Anti-cd40 antibodies and methods of use
MX2016002826A (en) Anti-b7-h1 antibodies for treating tumors.
JO3330B1 (en) Cgrp antibodies
PH12014501164A1 (en) Anti-cd98 antibodies and methods of use thereof
MX2013011479A (en) Anti-fgfr4 antibodies and methods of use.
SG10201902924RA (en) Antibodies that bind ebola glycoprotein and uses thereof
WO2012173846A3 (en) Peptidomimetic macrocycles
MX2014004022A (en) ANTI-HtrA1 ANTIBODIES AND METHODS OF USE.
IN2014DN05885A (en)
NZ626242A (en) Anti-asic1 antibodies and uses thereof
WO2012166626A8 (en) Reagents and methods for treating dental disease
MX2014013678A (en) Agents for influenza neutralization.
PH12015501360A1 (en) Bmp-6 antibodies
MX2015008534A (en) ANTI- INTEGRIN ß1 ANTIBODY COMPOSITIONS AND METHODS OF USE THEREOF.
MX2015002465A (en) Monoclonal antibodies for enhancing or inhibiting insulin-like growth factor 1 (igf-1).
MX2013011629A (en) Use of an agent consisting of antibodies and/or insulin-like growth factor antagonists.
UA109148C2 (en) Compositions based on anti-vegfr-3 antibody